Literature DB >> 10856530

Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease.

H A Schwertner1, J R Fischer.   

Abstract

Studies were performed to determine if serum bilirubin, when combined with various lipid and lipoprotein risk factors, enhances our ability to predict coronary artery disease (CAD). This hypothesis was tested in a retrospective study of 644 middle-aged males who had undergone coronary angiography. The traditional risk factors of cholesterol, high density lipoprotein cholesterol (HDL-C), cholesterol/HDL-C ratios, triglycerides, age, cigarette smoking, and systolic blood pressure were tested by discriminant analysis, as were various cholesterol/bilirubin, cholesterol/(HDL-C+bilirubin), and low-density lipoprotein cholesterol (LDL-C)/(HDL-C+bilirubin) ratios. Each of these bilirubin-containing ratios was found to be an independent risk predictor when tested with the traditional risk factors. When the LDL-C/(HDL-C+bilirubin) ratio was included with the traditional risk predictors, it improved the prediction of severe CAD from 28.4 to 35.3% and the overall correct classification of CAD from 68.3 to 71.1%. When the 75th percentile was used as a cut-point, the diagnostic sensitivities obtained with cholesterol/(HDL-C+bilirubin) ratios (52.1%) and LDL-C/(HDL-C+bilirubin) ratios (51.7%) were better than those obtained with cholesterol/HDL-C ratios (40.4%) (P=0.033 and 0.048, respectively). LDL-C/(HDL-C+bilirubin) ratios also improved the prediction of severe CAD over those obtained with LDL-C/HDL-C ratios (43.4%); however, the changes were not statistically significant (P=0.096). If confirmed in other populations, serum bilirubin may be combined with LDL-C/HDL-C ratios, cholesterol/HDL-C ratios, cholesterol, or with various apolipoproteins to improve the prediction of CAD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856530     DOI: 10.1016/s0021-9150(99)00387-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study.

Authors:  Jing-Ping Lin; L Adrienne Cupples; Peter W F Wilson; Nancy Heard-Costa; Christopher J O'Donnell
Journal:  Am J Hum Genet       Date:  2003-02-28       Impact factor: 11.025

2.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

3.  Stenotic coexistence among coronary, renal and extracrainal arteries in Chinese patients.

Authors:  Yuqiang Fang; Xian Shu; Chenming Yang; Xukai Wang; Hongyong Wang; Chunjiang Fu; Weibin Shi; Ye Zhang; Qiao Chen; Li Yang; Chunyu Zeng
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 4.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

5.  Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference.

Authors:  Patrick F McArdle; Brian W Whitcomb; Keith Tanner; Braxton D Mitchell; Alan R Shuldiner; Afshin Parsa
Journal:  BMC Cardiovasc Disord       Date:  2012-03-14       Impact factor: 2.298

6.  Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study.

Authors:  Phillip E Melton; Karin Haack; Harald H Göring; Sandy Laston; Jason G Umans; Elisa T Lee; Richard R Fabsitz; Richard B Devereux; Lyle G Best; Jean W Maccluer; Laura Almasy; Shelley A Cole
Journal:  Am J Hum Biol       Date:  2011 Jan-Feb       Impact factor: 1.937

7.  The role of bilirubin and its protective function against coronary heart disease.

Authors:  A Erkan; B Ekici; M Uğurlu; G Iş; R Seker; S Demirtaş; S Korkmaz
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

8.  Higher serum total bilirubin concentration is associated with lower risk of renal insufficiency in an adult population.

Authors:  Ang-Tse Lee; Ya-Yu Wang; Shih-Yi Lin; Jiin-Tsae Liang; Wayne Huey-Herng Sheu; Yuh-Min Song; Wen-Dau Chang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  A novel predictor of infarct-related artery patency before percutaneous intervention and in-hospital outcomes for ST-segment elevation myocardial infarction patients: serum bilirubin level.

Authors:  Halit Acet; Faruk Ertş; Mehmet Ata Akıl; Nihat Polat; Mesut Aydın; Abdurrahman Akyüz; Hilal Ayçiçek; Sait Alan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-06-26       Impact factor: 1.426

10.  Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis.

Authors:  Maria do Sameiro-Faria; Michaela Kohlova; Sandra Ribeiro; Petronila Rocha-Pereira; Laetitia Teixeira; Henrique Nascimento; Flávio Reis; Vasco Miranda; Elsa Bronze-da-Rocha; Alexandre Quintanilha; Luís Belo; Elísio Costa; Alice Santos-Silva
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.